This edition contains the following: First FDA-Approved NASH Drug Expected in 2020: Quick Facts...
Read More
This edition contains the following: Living Donor Liver Transplantation An Update on Nonalcoholic Steatohepatitis...
Bottom Line: With these therapies, only one in 1,000 hepatitis C patient will remain...
A disease you may never have heard of is slowly damaging the health of...
By Naim Alkhouri, Fred Poordad, and Eric Lawitz Nonalcoholic fatty liver disease (NAFLD) is considered...
This edition contains the following: A New First-Line Oral Treatment for Advanced Hepatocellular Carcinoma...
GALA Dallas Conference – 2018 Click link for access to slides. WELCOME/INTRODUCTION• Conference Chairs: Mack...
This edition contains the following: Autoimmune Hepatitis: Current And Future Treatment Options Cholangiocarcinoma: Diagnosis...
As we conclude another year now past the peak of hepatitis C research, HCV...